β-Rutinose

CAS : 26184-96-3

Ref. 3D-BBA18496

Informations sur le produit

• Nom: β-Rutinose
• Synonymes: (2R,3R,4R,5S,6S)-6-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]methoxy}tetrahydro-2H-pyran-2,3,4,5-tetrol (non-preferred name), 6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucose, 6-O-(6-Deoxy-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)-β-<smallcap>D</span>-glucopyranose, 6-O-(6-deoxy-alpha-L-mannopyranosyl)-D-glucose, Rutinose, β-, β-<span class="text-smallcaps">D</smallcap>-Glucopyranose, 6-O-(6-deoxy-α-<smallcap>L</span>-mannopyranosyl)-

Description

Beta-rutinose is a potent kinase inhibitor that has shown anti-tumor activity in Chinese hamster ovary (CHO) cells. It inhibits the activity of cyclin-dependent kinases, which are essential for cell division and proliferation. Beta-rutinose has been shown to induce apoptosis in human cancer cells, making it a promising candidate for anticancer therapy. This compound is an analog of rutin, a flavonoid found in many plants, and has been shown to have potent anticancer effects in vitro and in vivo. Beta-rutinose inhibits the growth of cancer cells by blocking the activity of specific kinases involved in tumor progression, making it an attractive target for developing new cancer therapies. Additionally, this compound has been found to be effective at reducing protein levels associated with cancer cell growth and proliferation.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 326.3 g/mol
• Formule: C₁₂H₂₂O₁₀
• Degré de pureté: Min. 95%